TAN
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UNTTED STATES DEPARTMENT OF COMMERCE
`United States Patent and Tradamark Office
`Address: COMMISSIONER FOR PATENTS
`PO Box 1450
`Alexamlna. Vinnnia 22313-1450
`FW,LIS
`
`10/502.685
`O7/27/2004
`Nayna Govind
`100629-US-PCT
`CONFIRMATION NO. 7568
`
`44992
`ASTRAZENECA R&D BOSTON
`
`oGHTEHOUSEDAE
`
`POWER OF ATTORNEY NOTICE
`
`gLNL
`
`Date Mailed: 07/10/2014
`
`NOTICE REGARDING CHANGE OF POWER OF ATTORNEY
`
`This is in response to the Powerof Attorneyfiled 06/24/2014.
`
`* The Powerof Attorney to you in this application has been revoked by the applicant. Future correspondence
`will be mailed to the new address of record(37 CFR 1.33).
`
`Annturner myles/
`
`
`Office of Data Management, Application Assistance Unit (571) 272-4000, or (571) 272-4200, or 1-888-786-0101
`
`page 1 of 1
`
`1
`
`Complex Ex. 1002, part 1
`Complex Ex. 1002, part 1
`of 2
`of 2
`
`1
`
`

`

`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UNTTED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISAIONER FOR PATENTS
`PO Box 1450
`Alexanlna. Vinunia 22313-1450
`Sree ge
`
`10/502,685
`07/27/2004
`Nayna Govind
`05629 1-5543
`CONFIRMATION NO. 7568
`
`9629
`
`W111PENNSYLVANIAAVENUENW.
`
`WASHINGTON, DC 20004
`
`POA ACCEPTANCE LETTER
`
`OEEMCOC8080800000A
`
`Date Mailed: 07/10/2014
`
`NOTICE OF ACCEPTANCE OF POWER OF ATTORNEY
`
`This is in response to the Power of Attorney filed 06/24/2014.
`
`The Power of Attorney in this application is accepted. Correspondencein this application will be mailed to the
`above address as provided by 37 CFR 1.38.
`
`fnmturner niyles/
`
`
`Office of Data Management, Application Assistance Unit (571) 272-4000, or (671) 272-4200, or 1-888-786-0101
`
`page 1 of 1
`
`2
`
`

`

`
`
`PTOPMSBiS1A (12-08)
`Approved for use through 11/30/2017, OMB 0651-0945
`US Patanl and Tradémark Office, U.S. DEPARTMENT OF COMMERCE
`Under ihe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB contral number.
`
`Patent Number
`PATENT - POWER OF ATTORNEY
`Issue Date
`July 20, 2010
`_| duly20
`OR
`:
`N
`REVOCATION OF POWER OF ATTORNEY |fitst NamedInventor sown ayne
`
`
`WITH A NEW POWER OF ATTORNEY
`Title
`Composition for Inhalation
`
`a
`
`AND
`
`| hereby revoke all previous powers of attorney given in the above-identified patent.
`[| A Power of Atlorney is submitied herewith.
`OR
`
`lhereby appcint Practtioner(s) associated with the folowing Customer Number as myfour
`altorney{s} or agent(¢) with respect to the patent identified above, and to transact all business in
`the United States Patent and Trademark Office cannected therewith:
`
`iggg2g
`|
`
`Ehereby appoint Prectitioner{s) named below as my/our attorney(s) or ageni{s) with respect to the patant identified
`above, and io transact all business in the United States Patent and Trademark Office connected lherewith:
`
`Praciilioner(s) Name
`
`Registratian Number
`
`
`
`
`Please recognize of change the correspondence address for the abave-identifiad patantto:
`x] The address associated with the above-mentioned Gustamer Number,
`OR
`
`[| The addzvess assoclated with Customer Number:
`
`OR
`-1
`C7]
`Firm or
`|k
`Individual Name
`Address
`
`
`
`
`
`‘Totalof1 forms are submitted.
`
`
`City
`“Country
`Telephone
`lam the:
`[ Inventor, having ownership of the patent.
`“OR
`a Patent owner,
`[I Statement under 37 CFR 3.73{b} (Form PTOSS6/96} submitted herewith or filed on
`
`
`
`ate
`
`Téelaphone|+1.781.8394054
`
`.
`
`NOTE: Signatures of alt the invantors of palent owners of the enlire inlerest or their repraseniative(s} are required. Submil mulkpte forms Hf mare than one
`signature & required, see below”.
`SZ]
`‘This collaclion ofinformation is requited by 37 CFR 131, 1.32 and 4.33. The mfgrmation is required (¢ oblsin or relain a benelil by the public which is to ile (and by the
`USPTO to process) an application. Confidenliality is governed by 35 0.8.6. 122 and 47 CFR 411 and 1 14. This coltection 5 esumaied {0 lake 3 minutes to compiete,
`including gathering, prepanng, and submitting tha comptaled appliealion font ta the USPTO. Time will very depending upon the individual case, Any carments on
`{he ameunt of time you require lo complete this form and/or suggestions for redustng this burden, should be sent ic the Chief Information Officer, UG. Patent and
`Trademark Oifice, U.S. Gepariment of Gommerce, P.O. Gox 1450, Alexandria, VA 22313-1460. DO NOT SEND FEES OR COMPLETED FORMS TO THIS
`ADDRESS. SENO TO Commissioner for Patents, P.G. Box $450, Alexandria, VA 22313-1450.
`
`if you need assisiance in completing the form, call 1-800-PTO-9 799 and select option 2.
`
`3
`
`

`

`PTOMS8/96 (07-09)
`Approved for use through O7/31/2012. OMB 0851-0041
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under ine Papeowork Reduction Act of 1995, no persons are required to respond to.a oulleviion of information unless if displays @ vad OMB conirel quinber.
`
`ieeetare
`Applicant/Patent Gwmner: Govind et all
`Application No/PatentNo.; 7,769,928|Fiileddfisswe Date: uly20, 2010
`Titled:
`7
`Composition For Inhalation
`
`AstraZeneca AB
`(Name of Assignee)
`
`slates thatit Js:
`
`corporation
`(ype of Assignee, ¢.g.. comporalion, partnership, university, government agency, etc.
`
`[<]
`
`the assignee ofthe entire right, tite, and interest in;
`
`|| an assignee of less than the entire right, tile, and interest in
`(The extent (by percantage) of ts ownership interestis HL OF
`
`|] the assignee of an undivided interest in the entirety of (a complete assignment fram one of the joint inventors was made)
`3
`ihe patent application/patentidentified above, oy virtua of aither:
`
`STATEMENT UNDER 37 CFR 3.73{b}
`
`A |
`
`An assignment from the Inventor(s} of the patent application/paient identified above. The assignment was recordad in
`the United States Patent and Trademark Office at Real
`015506
`Frame 0145
`Jor for which a
`copy therefore is altached,
`
`OR
`B.i| A chain oftitle from the inventor(s}, of the patent eppiication/patentidentified above, to the current assignaa as follows:
`+. Fram:
`To.
`
`2. From.
`
`3. From:
`
`The document! was recorded in Ihe United States Patent and Trademark Office at
`
`Reel
`
`__,
`
`Frame
`
`oo« ~=6for which a copy thereofis attached.
`Ta:
`
`The document was recorded in the United States Patani and Trademarx Office al
`
`Reel
`
`, Frame.
`
`,
`
`or far which a copy thereof is attached.
`
`Tha document was recorded in the United States Patent and Trademark Offices at
`
`Frame
`
`.
`
`of for which a copy thereof is attached,
`
`To:
`
` [|
`
`Additional decuments in the chain oftile are listed on a supplemenial sheet(s).
`
`Dx] As required by 37 CFR 3 73(b)(1)(i), the dacumentary evidence of the chain oftitle from the original ownerto the assignee was,
`or concurrently is being, submitted for recordation pursuantlo 37 CFR 3,11.
`[NOTE: A separate copy {ie., a true copy of the orginal assignment document(s}) must be submitted to Assignment Division in
`accordance wilh 37 CFR Part 3, to record the assignment in ihe records ofthe USPTO. See MPEP 302.08]
`
`The undersigned (whosetitlais supplied below) is authorized to act on behalf of the agsignes.
`
`. Loum
`
`oui
`
`Date
`
`Patent Attorney, Astrazenegg
`Meaghan L. Richmond; Reg. No. 61402
`
`Title
`Printed or Typed Name
`This cotfection of information is required by 37 CFR 3.73tb}. The information is required to obtain or retain a benefit by the publly whicdis io file (and by tha USPTO to
`process} an application, Conkdentialily is governed by 35 U.S.C, 122 and 37 CFR 1.17 and 1.14 This collactionis estimated to take 12 tminutes to complete, molding
`gathering, preparing, and submitting ime completed application formle the USPTO. Time will vary depending upoo Ihe indiacual case. Any comments on the amountot lime
`You fequire to completa ths form and/or suggestions [or regucing this burden, should be sent to the Chief Information Officer, U.S. Palont and Tradernark Offiee, U.S.
`Depariment of Commerce P.O. Box 1450, Alexandria, VA 22913-1450, DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS SEND TO: Commissioner
`for Patents, P.O. Box 1490, Alexandria, VA 22393-4450,
`
`Hyau need assistance in completing fhe form, cat t-B00-PTO-9 199 anu select option 2
`
`4
`
`4
`
`

`

`
`
`Electronic Acknowledgement Receipt
`
`
`EFS ID:
`
`19398477
`
`Application Number:
`10502685
`
`
`International Application Number:
`
`7568
`Confirmation Number:
`
`
`Title of Invention:
`
`COMPOSITION FOR INHALATION
`
`
`
`First Named Inventor/Applicant Name:
`
`Nayna Govind
`
`449902
`Customer Number:
`
`
`Filer:
`
`Gregory Thomas Lowen
`
`Filer Authorized By:
`
`
`Attorney Docket Number:
`
`100629-US-PCT
`
`Receipt Date:
`24-JUN-2014
`
`
`Filing Date:
`
`27-JUL-2004
`
`
`
`Time Stamp: 18:07:42
`
`Application Type:
`
`U.S. National Stage under 35 USC 371
`
`Paymentinformation:
`
`
`Submitted with Payment
`no
`
`
`File Listing:
`
`Document
`ee
`:
`File Size(Bytes}/
`Multi
`Pages
`
`
`
`
`Number Message Digest|Part/.zip|Document Description File Name (ifappl.)
`
`90895
`
`Warnings: Information:
`
`
`
`
`1
`
`cM Fb2adidalkeced? 324020732a75
`lelFa
`
`
`Power of Attorney
`
`5543P0A. pdf
`
`no
`
`1
`
`5
`
`

`

`
`
`Assignee showing of ownership per 37
`
`1
`no
`5§543Statement.pdf
`CFR 373.
`2
`OiaF71] She33h? 3obdah |
`| falc
`Oct
`
`
`
`
`Warnings:
`Information:
`Total Files Size (in bytes){ 173194
`
`|
`|
`
`
`
`New International Application Filed with the USPTO as a Receiving Office
`If a new international application is being filed and the international application includes the necessary components for
`an international filing date (see PCT Article 11 and MPEP 1810}, a Notification of the International Application Number
`and of the International Filing Date (Form PCT/RO/105) will be issued in due course, subject to prescriptions concerning
`national security, and the date shown on this Acknowledgement Receiptwill establish the international filing date of
`the application.
`
`
`
`
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents,
`characterized by the applicant, and including page counts, where applicable.It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`New Applications Under 35 U.S.C. 111
`If a new application is being filed and the application includes the necessary componentsfora Filing date (see 37 CFR
`1.53(b)-(d} and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shown on this
`Acknowledgement Receipt will establish the filing date of the application.
`
`National Stage of an International Application under 35 U.S.C. 371
`If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903indicating acceptance of the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`
`6
`
`

`

`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UNTTED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISAIONER FOR PATENTS
`PO Box 1450
`Alexanlna. Vinunia 22313-1450
`Sree ge
`
`10/502,685
`07/27/2004
`Nayna Govind
`100629-US-PCT
`CONFIRMATION NO. 7568
`
`44992
`
`35GATEHOLISEDRIVE.
`
`WALTHAM, MA 02451-1215
`
`POA ACCEPTANCE LETTER
`
`OEMOLC
`
`Date Mailed: 06/09/2014
`
`NOTICE OF ACCEPTANCE OF POWER OF ATTORNEY
`
`This is in response to the Power of Attorney filed 05/28/2014.
`
`The Power of Attorney in this application is accepted. Correspondencein this application will be mailed to the
`above address as provided by 37 CFR 1.38.
`
`fnmturner niyles/
`
`
`Office of Data Management, Application Assistance Unit (571) 272-4000, or (671) 272-4200, or 1-888-786-0101
`
`page 1 of 1
`
`7
`
`

`

`SSWA
`3
`
`
`
`ONITED STATES PATENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Tradamark Offiee
`Address COMMISSIONER FOR PATENTS
`Pd Box 1440
`Alexamlina. Virgunla 72313-1450
`WLEtG gov
`
`APPLICATION NUMBER
`FILING OR 371001 DATE
`FIRST NAMED APPLICANT
`ATTY. DOCKET NO/TITLE
`10/502,685
`07/27/2004
`Nayna Govind
`
`9629
`MORGAN LEWIS & BOCKIUS LLP (WA)
`1111 PENNSYLVANIA AVENUE NW
`
`WASHINGTON, DC 20004
`
`CONFIRMATION NO. 7568
`
`POWER OF ATTORNEY NOTICE
`
`UMNWOMANLO
`
`Date Mailed: 06/09/2014
`
`NOTICE REGARDING CHANGE OF POWER OF ATTORNEY
`
`This is in response to the Power of Attorney filed 05/28/2014.
`
`¢The Power of Attorney to you in this application has been revoked by the applicant. Future correspondence
`will be mailed to the new address of record(37 CFR 1.33).
`
`/mniturner nyles/
`
`
`Office of Data Management, Application Assistance Unit (571) 272-4000, or (571) 272-4200, or 1-888-786-0101
`
`page 1 of 1
`
`8
`
`

`

`PTOMSB61A (12-08)
`Approved for use through 11/30/2011. OMB 0651-0035
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays 4 valid OMB control number.
`
`PATENT - POWER OF ATTORNEY
`OR
`REVOCATION OF POWER OF ATTORNEY
`
`Patent Number 7750328
`7,759,328
`20 July 2010
`OVIND
`
`i
`[~“t“8med Inventor
`
`AND
`
`| hereby revoke all previous powers of attorney given in the above-identified patent.
`[| A Powerof Attorney is submitted herewith.
`OR
`
`OR
`C]
`
`| hereby appoint Practitioner(s) associated with the following Customer Number as my/our
`attorney(s) or agent(s) with respect te the patent identified above, and to transact all business in
`the United States Patent and Trademark Office connected therewith:
`
`|4qga?
`
`| hereby appoint Practitioner(s) named below as my/our attorney(s) or agent(s) with respect to the patent identified
`above, and to transact all business in the United States Patent and Trademark Office connected therewith:
`
`Practitioner(s} Name
`
`Registration Number
`
`
`
`
`
`Please recognize or change the correspondence addressfor the above-identified patent to:
`The address associated with the above-mentioned Customer Number.
`
`oR
`[] The address associated with Customer Number:
`OR
`Firm or
`Individual Name
`
`payTOOCOCOCC‘édSWBTTC—“*é‘irYTSCSC“‘(NSN’NCO
`Pcomty|
`Tolephone a
`lam the:
`[| Inventor, having ownership of the patent.
`OR
`Patent owner.
`Statement under 37 CFR 3.73(b) (Form PTO/SB/96) submitted herewith or fled on
`SIGNATUREof Inventor or Patent Owner
`
`/Meaghan L. Richmond/
`May 28, 2014
`
`Meaghan L. Richmond Telephone|+1.781.839.4054
`Patent Attomey: Astrazeneca AB
`Title and Compan
`
`NOTE: Signatures of all the inventors or patent owners of the entire interest or their representative(s) are required. Submit multiple forms if more than one
`signalure is required, see below”.
`
`*Total of
`
`_1
`
`forms are submitted.
`
`This collection of information is required by 37 CFR 1.31, 1.32 and 1.33. The information is required to obtain or retain a benefit by the public which is Lo file (and by the
`USPTO te process) an application. Confidentiality is govemead by 35 U.S.C, 122 and 37 CFR 1.11 and 1.14. This collection is eslimaled lo take 3 minules lo complete,
`including gathering, preparing, and submitting the completed application form to the USPTO. Time will yary depending upon the individual case, Any comments on
`the amount of time you require to complete this form and/or suggestions for reducing this burden, shoukd be sent to the Chief Information Officer, US. Patent and
`Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA) 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS
`ADDRESS. SEND TO. Commissionerfor Patents, P.O. Box 1450, Alexandria, VA 22313-1450,
`
`ifyou need assistance in completing the form, calf 1-800-PTO-9199 and select option 2.
`
`9
`
`9
`
`

`

`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection
`with your submission of the attached form related to a patent application or patent. Accordingly,
`pursuant to the requirements of the Act, please be advised that: {1} the general authority for the
`collection of this information is 35 U.S.C. 2(5)(2); (2) furnishing of the information solicited is voluntary;
`and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark
`Office is to process and/or examine your submission related to a patent application or patent. If you do
`not furnish the requested information, the U.S. Patent and Trademark Office may not be able ta
`process and/or examine your submission, which may result in termination of proceedings or
`abandonment of the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1. The information on this form will be treated confidentially to the extent allowed under the
`Freedom of Information Act (6 U.S.C. 552) and the Privacy Act (5 U.S.C 552a)}, Records from
`this system of records may be disclosed to the Department of Justice to determine whether
`disclosure of these records is required by the Freedom of Information Act.
`in the course of
`A record from this system of records may be disclosed, as a routine use,
`presenting evidence to a court, magistrate, or administrative tribunal, including disclosures to
`opposing counsel in the course of settlement negotiations.
`to a Member of
`A record in this system of records may be disclosed, as a routine use,
`Congress submitting a request involving an individual, to whom the record pertains, when the
`individual has requested assistance from the Member with respect to the subject matter of the
`record.
`A record in this system of records may be disclosed. as a routine use, to a contractor of the
`Agency having need for the information in order to perform a contract. Recipients of
`information shall be required to comply with the requirements of the Privacy Act of 1974, as
`amended, pursuant to § U.S.C. 552a(m).
`A record related to an International Application filed under the Patent Cooperation Treaty in
`this system of records may be disclosed, as a routine use, to the International Bureau of the
`World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
`A record in this system of records may be disclosed, as a routine use, to another federal
`agency for purposes of National Security review (35 U.S.C. 181} and for review pursuant to
`the Atomic Energy Act (42 U.S.C. 218(c}).
`A record from this system of records may be disclosed, as a routine use, to the Administrator,
`General Services, or his/her designee, during an inspection of records conducted by GSA as
`part of that agency's responsibility to recommend improvements in records management
`practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall
`be made in accordance with the GSA regulations governing inspection of records for this
`purpose, and any other relevant (ie, GSA or Commerce) directive. Such disclosure shall not
`be used to make determinations aboutindividuals.
`A record from this system of records may be disclosed, as a routine use, to the public after
`either publication of the application pursuant to 35 U.S.C. 122(b) or issuance of a patent
`pursuant to 36 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37
`CFR 1.14, as a routine use, to the public if the record was filed in an application which
`became abandoned of in which the proceedings were terminated and which application is
`referenced by either a published application, an application open to public inspection or an
`issued patent.
`A record from this system of records may be disclosed, as a routine use, to a Federal, State,
`or local law enforcement agency,if the USPTO becomes awareof a viclation or potential
`violation of law or regulation.
`
`10
`
`10
`
`

`

`PTOfSB/96 (07-09)
`Approved far usa through 07/31/2012 OMB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number.
`
`STATEMENT UNDER 37 CER 3.73(b)
`
`COMPOSITION FOR INHALATION
`
`AstraZeneca AB
`(Name of Assignee}
`
`states that it is:
`
`,a
`
`Corporation
`(Types of Assignes, a.g., corporation, partnership, university, government agency, etc.
`
`1.
`
`the assignee of the entire right, title, and interest in;
`
`an assignee ofless than the entire right, title, and interest in
`(The extent (by percentage} of its ownership interestis
`
`%), OF
`
`the assignee of an undivided interest in the entirety of (a complete assignment from one of the joint inventors was made)
`3, []
`the patent application/patent identified above, by virtue of either:
`
`A.
`
`An assignment from the inventor(s)} of the patent application/patent identified above. The assignment was recorded in
`the United States Patent and Trademark Office at Reel 015506
`, Frame 0145
`_ or for which a
`copy therefore is attached.
`
`Applicant/Patent Owner, Govind etal.
`
`Application No./Patent No.: 7,759,328
`Filed/Issue Date. 20 July 2010
`Titled:
`
`Patent Attorney, Astrazeneca Printed or Typed Name
`
`A chain oftitle from the inventer(s), of the patent application/patent identified above, to the current assignee as follows:
`
`1. From:
`
`2. From:
`
`3. From:
`
`To:
`
`The document was recorded in the United States Patent and Trademark Office at
`
`Reel
`
`,
`
`Frame
`
`,
`
`Of for which 4 copy thereof is attached.
`
`The document was recorded in the United States Patent and Trademark Office at
`
`Reel
`
`,
`
`Frame
`
`,
`
`of for which a copy thereofis attached.
`
`To:
`
`The document was recorded in the United States Patent and Trademark Office at
`
`Reel
`
`,
`
`Frame
`
`,
`
`of for which a copy thereof is attached.
`
`To:
`
`[]
`
`Additional documents in the chain oftitle are listed on 4 supplemental sheet(s).
`
`As required by 37 CFR 3.73(b}(1)(i}, the documentary evidence of the chain oftitle from the original owner to the assignee was,
`or concurrently is being, submitted for recordation pursuant to 37 CFR 3.11.
`
`[NOTE: A separate copy (/¢@., a true copy of the original assignment document(s}} must be submitted to Assignment Division in
`accordance with 37 CFR Part 3, to record the assignment in the recerds of the USPTO. See MPEP 302.08]
`
`The undersigned (whosetitle is supplied below) is authorized to act on behalf of the assignee.
`{Meaghan L. Richmeond/
`Signature
`
`May 28, 2014
`Date
`
`Meaghan L. Richmond; Reg no. 61402
`
`Title
`This collection of information is required by 37 CFR 3.73{b)}. The informationis required to obtain or retain a benefit by the public which is tofile {and by the USPTO to
`process) an application. Confidentiality is govemed by 35 U.S.C, 122 and 37 CFR 1.11 and 1.14. This collection is ¢stimated to take 12 minutes to complete, including
`gathering, preparing, and submitting tha completed application farm to tha USPTO. Time will vary dapending upon tha individual case. Any comments on tha amount of time
`you require to complete this form and/or suggestions for reducing this burden. should be sent te the Chief Information Officer, U.S. Patent and Trademark Office, US.
`Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner
`for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`1 1
`ff you need assisfance in completing the form. call 1-800-PTO-9799 and select aption 2.
`
`11
`
`

`

`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection
`with your submission of the attached form related to a patent application or patent. Accordingly,
`pursuant to the requirements of the Act, please be advised that:
`(1} the general authority for the
`collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary;
`and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark
`Office is to process and/or examine your submission related to a patent application or patent. If you do
`not furnish the requested information, the U.S. Patent and Trademark Office may not be able ta
`process and/or examine your submission, which may result in termination of proceedings or
`abandonment of the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1. The information on this form will be treated confidentially to the extent allowed under the
`Freedom of Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records fram
`this system of records may be disclosed to the Departmentof Justice to determine whether
`disclosure of these records is required by the Freedom of Information Act.
`in the course of
`A record from this system of records may be disclosed, as a routine use,
`presenting evidence to a court, magistrate, or administrative tribunal, including disclosures to
`opposing counsel in the course of settlement negotiations.
`to a Member of
`A record in this system of records may be disclosed, as a routine use,
`Congress submitting a request involving an individual, to whom the record pertains, when the
`individual has requested assistance from the Member with respect to the subject matter of the
`record,
`A record in this system of records may be disclosed, as a routine use, to a contractor of the
`Agency having need for the information in order to perform a contract. Recipients of
`information shall be required to comply with the requirements of the Privacy Act of 1974, as
`amended, pursuant to 5 U.S.C. 552a(m)}.
`A record related to an International Application filed under the Patent Cooperation Treaty in
`this system of records may be disclosed, as a routine use, to the International Bureau of the
`World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
`A record in this system of records may be disclosed, as a routine use, to another federal
`agency for purposes of National Security review (35 U.S.C. 181) and for review pursuant to
`the Atomic Energy Act (42 U.S.C, 218(c}).
`A record from this system of records may be disclosed, as a routine use, to the Administrator,
`General Services, or his/her designee, during an inspection of records conducted by GSA as
`part of that agency's responsibility to recommend improvements in records management
`practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall
`be madein accordance with the GSA regulations governing inspection of records for this
`purpose, and any other relevant {(/e., GSA or Commerce) directive. Such disclosure shall not
`be used to make determinations about individuals.
`A record from this system of records may be disclosed, as a routine use, to the public after
`either publication of the application pursuant to 35 U.S.C. 122(b) or issuance of a patent
`pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37
`CFR 1.14, as a routine use, to the public if the record wasfiled in an application which
`became abandoned of in which the proceedings were terminated and which application is
`referenced by either a published application, an application open to public inspection or an
`issued patent.
`A record from this system of records may be disclosed, as a routine use, to a Federal, State,
`or local law enforcement agency,if the USPTO becomes aware of a violation or potential
`violation of law or regulation.
`
`12
`
`12
`
`

`

`
`
`Electronic Acknowledgement Receipt
`
`
`EFS ID:
`
`19150674
`
`
`
`Application Number: 10502685
`
`International Application Number:
`
`Confirmation Number:
`7568
`
`
`Title of Invention:
`
`COMPOSITION FOR INHALATION
`
`
`
`First Named Inventor/Applicant Name:
`
`Nayna Govind
`
`Customer Number:
`9629
`
`
`Filer:
`
`Meaghan Lynn Richmond/Jami Baumer
`
`
`
`Filer Authorized By: Meaghan Lynn Richmond
`
`Attorney Docket Number:
`
`Receipt Date:
`28-MAY-2014
`
`
`Filing Date:
`
`27-JUL-2004
`
`Time Stamp:
`17:09:34
`
`
`Application Type:
`
`U.S. National Stage under 35 USC 371
`
`Paymentinformation:
`
`
`Submitted with Payment
`no
`
`
`
`Warnings: Information: 13
`
`File Listing:
`
`ee
`:
`File Size(Bytes}/
`Document
`Pages
`
`
`
`
`Number Message Digest|Part/.zip|Document Description File Name (ifappl.)
`
`
`747089
`
`Power of Attorney
`PowerS681A.pdf
`no
`503d 147dd FdadPETSsaoIo?FID
`ween
`
`
`2
`
`1
`
`13
`
`

`

`
`
`Assignee showing of ownership per 37
`2
`no
`CFR 373.
`StatementSB96,pdf
`2
`AID lack67etcHiccda6 Ibe321911
`
`
`422936
`
`
`
`
`
`New International Application Filed with the USPTO as a Receiving Office
`If a new international application is being filed and the international application includes the necessary components for
`an international filing date (see PCT Article 11 and MPEP 1810}, a Notification of the International Application Number
`and of the International Filing Date (Form PCT/RO/105) will be issued in due course, subject to prescriptions concerning
`national security, and the date shown on this Acknowledgement Receiptwill establish the international filing date of
`the application.
`
`Warnings:
`Information:
`Total Files Size (in bytes){ 1170025
`
`
`
`
`
`|
`|
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents,
`characterized by the applicant, and including page counts, where applicable.It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`New Applications Under 35 U.S.C. 111
`If a new application is being filed and the application includes the necessary componentsfora Filing date (see 37 CFR
`1.53(b)-(d} and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shown on this
`Acknowledgement Receipt will establish the filing date of the application.
`
`National Stage of an International Application under 35 U.S.C. 371
`If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903indicating acceptance of the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`
`14
`
`14
`
`

`

`SSWA
`3
`
`
`
`ONITED STATES PATENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Tradamark Offiee
`Address COMMISSIONER FOR PATENTS
`Pd Box 1440
`Alexamlina. Virgunla 72313-1450
`WLEtG gov
`
`APPLICATION NUMBER
`FILING OR 371001 DATE
`FIRST NAMED APPLICANT
`ATTY. DOCKET NO/TITLE
`10/502,685
`07/27/2004
`Nayna Govind
`
`9629
`MORGAN LEWIS & BOCKIUS LLP (WA)
`1171 PENNSYLVANIA AVENUE RW
`
`WASHINGTON, DC 20004
`
`CONFIRMATION NO. 7568
`
`POA ACCEPTANCE LETTER
`
`Omage
`
`Date Mailed: 03/03/2014
`
`NOTICE OF ACCEPTANCE OF POWER OF ATTORNEY
`
`This is in response to the Power of Attorney filed 02/12/2014.
`
`The Power of Attorney in this application is accepted. Correspondencein this application will be mailed to the
`above address as provided by 37 CFR 1.38.
`
`ftrwoodson/
`
`
`
`Office of Data Management, Application Assistance Unit (571) 272-4000, or (671) 272-4200, or 1-888-786-0101
`
`page 1 of 1
`
`15
`
`15
`
`

`

`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UNTTED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISAIONER FOR PATENTS
`PO Box 1450
`Alexanlna. Vinunia 22313-1450
`Sree ge
`
`10/502,685
`07/27/2004
`Nayna Govind
`06275-410U51
`CONFIRMATION NO. 7568
`
`26164
`FISH & RICHARDSONP.C.
`
`PO BON 10a
`
`MINNEAPOLIS, MN 55440-1022
`
`POWER OF ATTORNEY NOTICE
`
`OLNNN
`
`Date Mailed: 03/03/2014
`
`NOTICE REGARDING CHANGE OF POWER OF ATTORNEY
`
`This is in response to the Power of Attorney filed 02/12/2014.
`
`*The Powerof Attorney to you in this application has been revoked by the assignee who hasintervened as
`provided by 37 CFR 3.71. Future correspondence will be mailed to the new address of record(37 GFR 1.33).
`
`/iwoodson/
`
`
`
`Office of Data Management, Application Assistance Unit (571) 272-4000, or (571) 272-4200, or 1-888-786-0101
`
`page 1 of 1
`
`16
`
`16
`
`

`

`PTOLAMAD (07-4 24
`Approved for use tirovah 1 V/agf20 1a, OMB 0651-9036
`U.S. Patent ang Trademark Office, U5 DEPARTMENT GF COMMERCE
`Under the Papenwork Reduction Act of 1935, no persons are renuired to respond to a collection of information untess il cispiays a vail COAG oocied number,
`
`I
`
`POWER OF ATTORNEY TO PROSECUTE APPLICATIONS BEFORE THE USPTO
`
`Therebyrevokeall previous powersofatlomey givenintheapplicationidentifiedintheattached stalement
`
`i hereby anpaird:
`| ed
`Practitianers associated with Custemer Number:
`OR
`
`As altornayis} of agentis) to represent ihe undersigned before the Linked States Patent and Trademark Office (USPTO) in connection with :
`BE any and ail patent applicalions assigned only to the undersigned arcarding te the USPTO assignment records or aesignments documents
`aiiached ip this form in accordance with 37 CFR 3.7aich
`
`P(e} to:
`
`Senior Paterit Director, Signed far and on behatf of AstraZeneca AB tretf sani
`
`Tetephone
`pemnantemaannenenenenneneemeeceet
`
`fap
`
`nen eeee esac eee cecneeen nee cee noes eeReem
`
`nen enesees anenenenenshbbhbhbbben seek nie beeeee AVNET NY
`
`$-181 85 Sddertalje
`Sweden
`
`A copy of this fonm, together with a statement under 37 CFR